Business

Rocket Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Awareness

—Educational Event at Carnegie Hall Featuring Patient Discussions and Opportunities for Patients and Families to Engage with Physicians and Researchers in

articleRocket Pharmaceuticals, Inc.February 6, 20205/company/rocket-pharmaceuticals-inc/news/rocket-pharmaceuticals-supports-rare-disease-dayr-and-joins-global-movement-to-raise
Rocket Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Awareness

About this update from Rocket Pharmaceuticals, Inc.

[{"type":"text","content":"\n—Educational Event at Carnegie Hall Featuring Patient Discussions and Opportunities for Patients and Families to Engage with Physicians and Researchers in the NY Healthcare Community—\n\n\n—Empire State Building to Illuminate in Pink, Blue, Purple and Green in Honor of Rare Disease Day–\n\n NEW YORK--(BUSINESS WIRE)--\nRocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, has joined forces with the 25-30 million Americans living with a rare disease and health care advocates around the world for Rare Disease Day® on February 29. Rare Disease Day is an annual awareness day dedicated to increasing public understanding of rare diseases and the impact on patients’ lives.\n\n\nThe theme of Rocket’s Rare Disease Day event, hosted in partnership with the RTW Charitable Foundation, is “I am RARE, hear me ROAR,” highlighting the Roaring ‘20s, a decade that saw the discovery of ground-breaking medicines including penicillin and insulin, ultimately saving millions of lives. Throughout the 1920s, advancements in science led to the development of many new technologies, vaccines and drugs improving healthcare for generations to this day. With the recent advent of genomic medicine and research tools, it has been suggested this decade may demonstrate the true potential of gene therapies.\n\n\nThe event will highlight patient artists who raise awareness of their disease through their artwork. At the event, patients will share their personal experiences living with a rare disease, and attendees will have an opportunity to engage in discussions with patients, caregivers, patient advocates, researchers and physicians. The purpose of the event is to provide all who attend an opportunity to learn more about rare disease and the need for new treatment options. In conjunction with the event, for the second year in a row the Empire State Building will be illuminated in pink, blue, purple and green (the colors of the rare disease day movement) in honor of Rare Disease Day and those impacted by rare disease.\n\n\n“At Rocket, our focus is first and foremost on the patients we are endeavoring to serve, and Rare Disease Day is the perfect time to not only bring that focus to the forefront of everyone’s mind, but to give patients the...

More updates from Rocket Pharmaceuticals, Inc.